Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe

Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe

Katharina Verleger, 1 John R Penrod, 2 Melinda Manley Daumont, 3 Caitlyn Solem, 4 Linlin Luo, 4 Cynthia Macahilig, 5 Nadine Hertel 6 1Pharmerit International, Berlin, Germany; 2Bristol-Myers Squibb, Princeton, NJ, USA; 3Bristol-Myers Squibb, Braine-L’alleud, Belgium; 4Pharmerit Interna...

Full description

Bibliographic Details
Main Authors: Verleger K, Penrod JR, Manley Daumont M, Solem C, Luo L, Macahilig C, Hertel N
Format: Article
Language:English
Published: Dove Medical Press 2020-01-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
carcinoma
non-small-cell lung observational study cost of illness health care costs
Online Access:https://www.dovepress.com/costs-and-cost-drivers-associated-with-non-small-cell-lung-cancer-pati-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/costs-and-cost-drivers-associated-with-non-small-cell-lung-cancer-pati-peer-reviewed-article-CEOR

Similar Items